Aegis Therapeutics Celebrates 10th Anniversary
October 28, 2013 12:26 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwired - Oct 28, 2013) - Aegis Therapeutics LLC is proud to announce it is celebrating its 10-year anniversary on October 31, 2013.
Aegis was founded by a renowned...
Aegis Awarded Its First Patent for Non-Invasive Delivery of a Protein Drug to the Central Nervous System (CNS)
October 09, 2013 04:01 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwired - Oct 9, 2013) - Aegis Therapeutics LLC announced today that it has been awarded its first patent for non-invasive delivery of a protein drug to the central nervous...
Aegis Technologies Providing Rapid Development of Super Generics
September 04, 2013 05:01 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwired - Sep 4, 2013) - Two "super generic" drugs utilizing Aegis Therapeutics Intravail technology for treatment of migraine headaches and seizures are rapidly advancing...
Aegis Awarded 3rd Patent for Fast Acting Migraine Nasal Spray Treatment
August 13, 2013 04:06 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwired - Aug 13, 2013) - Aegis Therapeutics LLC announced today that it has been awarded a third patent for fast acting formulations of triptans, a widely used class of drugs...
Biosuperior Formulations Reduce Industry Concerns About Biosimilar Pricing, Development Costs, and Patient Acceptance
April 02, 2013 04:10 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwired - Apr 2, 2013) - Concerns about the economic viability of biosimilars center around the high development cost relative to small molecule generics, and the difficulty of...
Aegis Awarded Patent for Absorption-Enhancing Self-Assembling Thixotropic Aqueous Hydrogels
December 11, 2012 19:54 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - Dec 11, 2012) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,329,220 providing proprietary compositions for absorption-enhancing...
Aegis Awarded Patent for Fast Acting Intravail(R)-Based Triptan Nasal Spray Formulations for Treating Migraine Headaches
September 24, 2012 12:17 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - Sep 24, 2012) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,268,791 providing fast acting formulations for triptans, a class...
Aegis Awarded Patent for Monoclonal Antibody Formulations That Avoid Oxidative Damage Due to Polysorbate Surfactants
July 24, 2012 03:01 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - Jul 24, 2012) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,226,949 providing broad protection for stabilized formulations of...
Aegis Therapeutics Awarded Patent for Octreotide Formulations Suitable for Oral and Metered Nasal Spray Delivery
May 21, 2012 04:01 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - May 21, 2012) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,133,863 providing broad protection for pharmaceutical composition of...
Second Parathyroid Hormone (PTH) Peptide Drug Patent Awarded to Aegis Therapeutics for Compositions Suitable for Metered Nasal Spray, Oral, and Injectable Delivery
May 16, 2012 13:51 ET
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - May 16, 2012) - Aegis Therapeutics LLC announced today that it has been awarded a second patent, U.S. Patent, No. 8,173,594, providing PTH and PTH analog compositions...